跳至主要内容
临床试验/NCT00079963
NCT00079963已完成不适用

Gender, Obesity, C-Reactive Protein, and Oxidative Stress

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2 个研究点 分布在 1 个国家目标入组 396 人开始时间: 2004年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
396
试验地点
2
主要终点
Change in high-sensitivity C-reactive protein (hsCRP)

研究概览

简要总结

This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatment effects. We will also determine whether gender, body fat, or menopausal status are associated with baseline concentrations of inflammation and oxidative stress markers.

详细描述

Participants will be given 1000 mg vitamin C or 800 IU vitamin E daily for 60 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Z

Placebo Comparator

Placebo

干预措施: Placebo (Dietary Supplement)

Y

Experimental

Vitamin E

干预措施: Vitamin E (Dietary Supplement)

X

Experimental

Vitamin C

干预措施: Vitamin C (Dietary Supplement)

结局指标

主要结局

Change in high-sensitivity C-reactive protein (hsCRP)

时间窗: 8-week intervention

次要结局

  • Change in blood pressure(8-week intervention)
  • Change in self-reported stress and psychosocial factors(8-week intervention)
  • Change in oxidative stress biomarkers (F2-Isoprostanes, malondialdehyde)(8-week intervention)
  • Association of gender, body fat, menopausal status with baseline concentrations of inflammation and oxidative stress biomarkers.(Baseline)

研究者

研究点 (2)

Loading locations...

相似试验

Gender, Obesity, C-Reactive Protein, and Oxidative... | 临床试验